In an animal model of SHPT, Hectorol (R), unlike calcitriol, reduced elevated levels of PTH and normalized serum calcium without causing hypercalcemia. The findings were presented today during Renal ...
Doxercalciferol 2mcg/mL; soln for IV inj. Give by IV bolus inj. Dialysis: initially 4mcg three times weekly after dialysis; titrate dose to maintain desired iPTH therapeutic range and serum calcium ...
Signing a definitive merger agreement, Genzyme Corp. plans to buy out Bone Care International Inc. for about $600 million in cash. Cambridge, Mass.-based Genzyme will gain Bone Care's main asset ...
New Report Added in ResearchMoz Reports Database Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic ...
Dr. Reddy’s is launching doxercalciferol injection, in 4 mcg/2 mL multidose vials. The product is the generic of Sanofi-Aventis’ Hectorol (doxercalciferol) injection 4 mcg/2 mL (2 mcg/mL) ...
Genzyme Corp yesterday said it will buy US company Bone Care International in an all-cash $600 million deal, sending the latter’s share price shooting skywards on the news. Genzyme Corp yesterday said ...
Dr. Reddy’s Laboratories (DRL) has launched Doxercalciferol injection, 4 mcg/2 mL (2 mcg/mL) multiple-dose vials, in the U.S. market. A therapeutic generic equivalent of Hectorol (doxercalciferol) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results